Trial Profile

A Phase II Study of TRC105 in Patients With Hepatocellular Carcinoma (HCC) Who Have Progressed on Sorafenib.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Carotuximab (Primary)
Indications Liver cancer
Focus Therapeutic Use

Most Recent Events

18 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
13 May 2015 As per a TRACON pharmaceuticals media release, National Cancer Institute (NCI) reported positive results from this study at the 2015 ASCO Gastrointestinal Cancers Symposium.
16 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com